• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rare case of recurrent refractory multiple myeloma with lipid deposition in the vertebral body: a case description.

作者信息

Li Yanju, Chen Ying, Liu Yang, Pei Yuanyuan, Zhang Kaiji, Wang Feiqing

机构信息

Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Clinical Medical Research Center, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.

出版信息

Quant Imaging Med Surg. 2025 Sep 1;15(9):8737-8741. doi: 10.21037/qims-24-2207. Epub 2025 Aug 18.

DOI:10.21037/qims-24-2207
PMID:40893546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12397708/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/9ef45541cfe8/qims-15-09-8737-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/9e99f2cc39fd/qims-15-09-8737-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/b48527293b07/qims-15-09-8737-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/9ef45541cfe8/qims-15-09-8737-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/9e99f2cc39fd/qims-15-09-8737-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/b48527293b07/qims-15-09-8737-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3088/12397708/9ef45541cfe8/qims-15-09-8737-f3.jpg

相似文献

1
Rare case of recurrent refractory multiple myeloma with lipid deposition in the vertebral body: a case description.罕见的复发性难治性多发性骨髓瘤伴椎体脂质沉积病例报告
Quant Imaging Med Surg. 2025 Sep 1;15(9):8737-8741. doi: 10.21037/qims-24-2207. Epub 2025 Aug 18.
2
Vertebral augmentation in patients with multiple myeloma: a pooled analysis of published case series.多发性骨髓瘤患者的椎体强化术：已发表病例系列的汇总分析
AJNR Am J Neuroradiol. 2014 Jan;35(1):207-10. doi: 10.3174/ajnr.A3622. Epub 2013 Jul 18.
3
Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions - results from the European M2Spine study group.多发性骨髓瘤患者因椎体病变接受手术的指征、时机及结果的实践差异——来自欧洲M2脊柱研究组的结果
J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05085-y.
4
Bisphosphonates in multiple myeloma.双膦酸盐在多发性骨髓瘤中的应用
Cochrane Database Syst Rev. 2001(4):CD003188. doi: 10.1002/14651858.CD003188.
5
Bisphosphonates in multiple myeloma.双膦酸盐在多发性骨髓瘤中的应用
Cochrane Database Syst Rev. 2002(3):CD003188. doi: 10.1002/14651858.CD003188.
6
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.贝兰他单抗马妥昔单抗治疗复发或难治性多发性骨髓瘤（DREAMM-2）：一项双臂、随机、开放标签、2 期研究。
Lancet Oncol. 2020 Feb;21(2):207-221. doi: 10.1016/S1470-2045(19)30788-0. Epub 2019 Dec 16.
7
Plain language summary on subcutaneous administration of isatuximab in people with relapsed and/or refractory multiple myeloma.关于皮下注射isatuximab治疗复发和/或难治性多发性骨髓瘤患者的简明语言总结。
Future Oncol. 2025 Aug;21(19):2415-2428. doi: 10.1080/14796694.2025.2526281. Epub 2025 Jul 16.
8
¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.¹⁸F-FDG PET/CT：多发性骨髓瘤及相关疾病的诊断和预后特征综述
Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14.
9
[Immunosubstitution of patients with refractory multiple myeloma treated with teclistamab, a bispecific antibody].[用双特异性抗体替雷利珠单抗治疗的难治性多发性骨髓瘤患者的免疫置换]
Ann Pharm Fr. 2025 Sep;83(5):1001-1010. doi: 10.1016/j.pharma.2025.04.008. Epub 2025 May 1.
10
Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index.评估复发/难治性多发性骨髓瘤患者的虚弱状态：患者报告的虚弱表型与国际骨髓瘤工作组虚弱指数的比较
J Geriatr Oncol. 2025 Jul;16(6):102266. doi: 10.1016/j.jgo.2025.102266. Epub 2025 Jun 4.

本文引用的文献

1
Measurements of peri-prostatic adipose tissue by MRI predict bone metastasis in patients with newly diagnosed prostate cancer.通过磁共振成像（MRI）测量前列腺周围脂肪组织可预测新诊断前列腺癌患者的骨转移情况。
Front Oncol. 2024 Apr 26;14:1393650. doi: 10.3389/fonc.2024.1393650. eCollection 2024.
2
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.髓外多发性骨髓瘤患者的自然病史、髓外疾病发展的预测因素和治疗结果。
Am J Hematol. 2023 Oct;98(10):1540-1549. doi: 10.1002/ajh.27023. Epub 2023 Jul 8.
3
Unraveling the Role of Peroxisome Proliferator-Activated Receptor β/Δ (PPAR β/Δ) in Angiogenesis Associated with Multiple Myeloma.
解析过氧化物酶体增殖物激活受体β/δ（PPARβ/δ）在多发性骨髓瘤相关血管生成中的作用。
Cells. 2023 Mar 25;12(7):1011. doi: 10.3390/cells12071011.
4
Multiple myeloma.多发性骨髓瘤。
Lancet. 2021 Jan 30;397(10272):410-427. doi: 10.1016/S0140-6736(21)00135-5.
5
Myeloma Cells Down-Regulate Adiponectin in Bone Marrow Adipocytes Via TNF-Alpha.骨髓瘤细胞通过肿瘤坏死因子-α下调骨髓脂肪细胞中的脂联素。
J Bone Miner Res. 2020 May;35(5):942-955. doi: 10.1002/jbmr.3951. Epub 2020 Jan 16.
6
Quantitative proton MR techniques for measuring fat.定量质子磁共振技术测量脂肪。
NMR Biomed. 2013 Dec;26(12):1609-29. doi: 10.1002/nbm.3025. Epub 2013 Oct 3.
7
Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells.相邻的脂肪细胞参与多发性骨髓瘤细胞的骨髓微环境。
Leukemia. 2007 Jul;21(7):1580-4. doi: 10.1038/sj.leu.2404658. Epub 2007 Mar 22.